Max Healthcare Institute Limited has announced the amalgamation of its wholly-owned subsidiaries, Crosslay Remedies Limited and Jaypee Healthcare Limited. The merger aligns with the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Entities Involved:

• Crosslay Remedies Limited (Transferor Company)
• Jaypee Healthcare Limited (Transferee Company)

Both companies operate in the healthcare sector and are fully owned by Max Healthcare. As of March 31, 2024, Crosslay Remedies reported a turnover of ₹797.39 crore, while Jaypee Healthcare recorded ₹420.35 crore.

Related Party Transaction:
The transaction falls under related party transactions; however, it is exempt under Regulation 23 of SEBI (LODR) Regulations, 2015, as it occurs between wholly-owned subsidiaries.

Rationale for the Amalgamation:
The merger aims to integrate and streamline business operations while improving financial and operational efficiency. Key benefits include:

• Business integration for enhanced financial strength
• Unified management for better administration
• Economies of scale and optimal asset utilization
• Reduced legal and regulatory compliance
• Synergies to accelerate growth and improve margins
• Unified cash flow management and efficient capital utilization

Share Exchange and Shareholding Pattern:
There is no cash consideration or change in the shareholding pattern of Max Healthcare, as the company itself is not a party to the scheme.

Max Healthcare remains committed to driving growth and enhancing stakeholder value through strategic business realignments.

Search Keyword: Max Health, Max Healthcare, Max Healthcare Share, Max Healthcare Stock, Max Healthcare Latest, Max Healthcare Latest News, Max Healthcare News Today, Max Healthcare Breaking News, Max Healthcare Latest Update, Result, Results, Company Results,